Alibaba Health Information Technology Ltd

HKSE:00241 (China)  
HK$ 3.27 (+2.19%) May 17
49.55
P/B:
2.55
Market Cap:
HK$ 52.62B ($ 6.74B)
Enterprise V:
HK$ 39.62B ($ 5.08B)
Volume:
89.39M
Avg Vol (2M):
46.22M
Also Trade In:
Volume:
89.39M
Avg Vol (2M):
46.22M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Alibaba Health Information Technology Ltd ( HKSE:00241 ) from 1990 to May 18 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Alibaba Health Information Technology stock (HKSE:00241) PE ratio as of May 18 2024 is 49.55. More Details

Alibaba Health Information Technology Ltd (HKSE:00241) PE Ratio (TTM) Chart

To

Alibaba Health Information Technology Ltd (HKSE:00241) PE Ratio (TTM) Historical Data

Total 1142
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 13
Alibaba Health Information Technology PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-18 49.5 2024-03-11 50.5
2024-05-17 49.5 2024-03-08 49.1
2024-05-16 48.5 2024-03-07 49.2
2024-05-14 48.5 2024-03-06 50.6
2024-05-13 48.3 2024-03-05 49.1
2024-05-10 48.0 2024-03-04 53.3
2024-05-09 48.0 2024-03-01 52.4
2024-05-08 46.4 2024-02-29 52.1
2024-05-07 46.2 2024-02-28 51.7
2024-05-06 48.2 2024-02-27 53.9
2024-05-03 49.7 2024-02-26 53.5
2024-05-02 49.7 2024-02-23 53.6
2024-04-30 44.9 2024-02-22 53.9
2024-04-29 45.9 2024-02-21 53.2
2024-04-26 44.7 2024-02-20 52.1
2024-04-25 41.7 2024-02-19 50.0
2024-04-24 41.7 2024-02-16 51.5
2024-04-23 40.8 2024-02-15 48.5
2024-04-22 40.3 2024-02-14 47.9
2024-04-19 39.5 2024-02-09 47.6
2024-04-18 40.1 2024-02-08 48.9
2024-04-17 40.0 2024-02-07 48.2
2024-04-16 39.7 2024-02-06 45.9
2024-04-15 41.2 2024-02-05 42.6
2024-04-12 41.7 2024-02-02 43.2
2024-04-11 43.0 2024-02-01 44.4
2024-04-10 43.8 2024-01-31 43.3
2024-04-09 43.8 2024-01-30 45.5
2024-04-08 42.6 2024-01-29 47.4
2024-04-05 42.4 2024-01-26 48.0
2024-04-03 45.0 2024-01-25 49.4
2024-04-02 46.5 2024-01-24 49.2
2024-03-28 48.2 2024-01-23 47.4
2024-03-27 48.0 2024-01-22 45.5
2024-03-26 49.1 2024-01-19 48.0
2024-03-25 48.5 2024-01-18 48.8
2024-03-22 49.9 2024-01-17 48.5
2024-03-21 53.6 2024-01-16 53.0
2024-03-20 51.7 2024-01-15 55.6
2024-03-19 51.4 2024-01-12 55.6
2024-03-18 53.2 2024-01-11 56.1
2024-03-15 50.9 2024-01-10 55.6
2024-03-14 51.7 2024-01-09 56.4
2024-03-13 52.6 2024-01-08 56.4
2024-03-12 53.9 2024-01-05 58.6

Alibaba Health Information Technology Ltd (HKSE:00241) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or "Dr. Deer", although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 97% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.